Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01559246 · ClinicalTrials.gov registry record
True Continuous ECG Monitoring (TCEM Study)
A clinical trial, sponsored by iRhythm Technologies.
- Completed
- Registry status
- 150
- Enrollment target
NCT01559246 is a clinical trial that has completed, run by iRhythm Technologies. The registered enrollment target is 150 participants.
The verdict
NCT01559246 has completed, sponsored by iRhythm Technologies.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to compare short term (up to 48 hours) traditional cardiac rhythm monitoring using a standard ambulatory Holter monitor versus long term (up to 14 days), continuous ambulatory cardiac rhythm monitoring using a new device cleared by the FDA (Zio® Patch), iRhythm Technologies, Inc., San Francisco CA) in patients with suspected cardiac arrhythmias.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01559246
The ClinicalTrials.gov registry entry for NCT01559246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is iRhythm Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01559246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01559246 about?
NCT01559246 is a clinical study titled "True Continuous ECG Monitoring (TCEM Study)". The purpose of this study is to compare short term (up to 48 hours) traditional cardiac rhythm monitoring using a standard ambulatory Holter monitor versus long term (up to 14 days), continuous ambulatory cardiac rhythm monitoring using a new device cleared by the FDA (Zio® Patch), iRhythm Technolog...
What is the current status of trial NCT01559246?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2012-04. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01559246?
This trial is sponsored by iRhythm Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.